PEGylated, extended insulins
    48.
    发明授权
    PEGylated, extended insulins 失效
    聚乙二醇化,延长胰岛素

    公开(公告)号:US08710001B2

    公开(公告)日:2014-04-29

    申请号:US13224538

    申请日:2011-09-02

    IPC分类号: A61K38/28

    CPC分类号: A61K38/28 A61K47/60

    摘要: PEGylated, extended insulins are insulins which, compared with human insulin, has one or more extensions extended from the A1, B1, A21 and/or B30 position(s), said extension(s) consist(s) of amino acid residue(s) and wherein a PEG moiety, via a linker, is attached to one or more of the amino acid residues in the extension(s). PEG is polyethyleneglycol. Such PEGylated, extended insulins have higher bioavailability and a longer time-action profile than regular insulin and are in particular suited for pulmonary administration and can, conveniently, be used to treat diabetes.

    摘要翻译: 聚乙二醇化的延长胰岛素是胰岛素,其与人胰岛素相比具有从A1,B1,A21和/或B30位置延伸的一个或多个延伸,所述延伸部分包含氨基酸残基(s) ),并且其中通过接头的PEG部分连接到延伸中的一个或多个氨基酸残基。 PEG是聚乙二醇。 这种聚乙二醇化的延长的胰岛素具有比常规胰岛素更高的生物利用度和更长的时间作用特征,并且特别适合于肺部给药,并且可以方便地用于治疗糖尿病。

    Acylated Single Chain Insulin
    50.
    发明申请
    Acylated Single Chain Insulin 审中-公开
    酰化单链胰岛素

    公开(公告)号:US20090099065A1

    公开(公告)日:2009-04-16

    申请号:US12282788

    申请日:2007-03-12

    IPC分类号: A61K38/28 C07K14/62

    CPC分类号: C12N15/62

    摘要: The invention is related to an acylated, single-chain insulin comprising the B- and the A-chain of human insulin or an analogue thereof connected by a connecting peptide, wherein a lysine residue being substituted for the natural amino acid residue in one of the positions A12-A23 in the human insulin A-chain has been chemically modified by acylation.

    摘要翻译: 本发明涉及包含人胰岛素的B链和A链的酰化单链胰岛素或其连接肽连接的类似物,其中赖氨酸残基取代其中一个的天然氨基酸残基 人胰岛素A链中的位置A12-A23已通过酰化化学修饰。